GlobalData tracks 5 drugs in development for Choriocarcinoma (Gestational Trophoblastic Neoplasia) by four companies/universities/institutes. The top development phase for Choriocarcinoma (Gestational Trophoblastic Neoplasia) is phase i, with four drugs in that stage.
Grifols gears up for FDA approval of fibrinogen replacement therapy
Share this article Grifols plans to file for regulatory approval for the AdFIrst (BT524) in both Europe and the US in Q4 of this year.